- Salarius Pharmaceuticals Inc at Ladenburg Thalmann Healthcare Conference TranscriptSep 29, 2022
- Q2 2022 Salarius Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022€35.92 (+6.21%)Earnings
- Q1 2022 Salarius Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022€47.2 (+31.55%)Earnings
- Q4 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptMar 10, 2022€70 (+4.17%)Earnings
- Salarius Pharmaceuticals Inc Asset Acquisition Agreement with DeuteRx LLC - M&A Call TranscriptJan 13, 2022
- Q3 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2021€144 (+0.70%)Earnings
- Salarius Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 29, 2021
- Q2 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021€136Earnings
- Salarius Pharmaceuticals Inc Virtual KOL & Investor Event Call TranscriptJun 21, 2021
- Q1 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2021€194 (+0.52%)Earnings
- Q4 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptMar 18, 2021€256 (+1.59%)Earnings
- Salarius Pharmaceuticals Inc to Discuss Advancements in the Phase 1/2 Clinical Trial of Seclidemstat Conference Call TranscriptFeb 24, 2021
- Q3 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptNov 11, 2020€124 (+5.08%)Earnings
- Q2 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2020€171 (-11.40%)Earnings
- Q1 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2020€152 (+2.01%)Earnings
- Salarius Pharmaceuticals Inc at SNN Network TranscriptNov 20, 2019
Salarius Pharmaceuticals Inc Virtual KOL & Investor Event Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Salarius Pharmaceuticals KOL & Investor Event conference call. At this time, all participants are in a listen-only mode. (Operator Instructions). Please be advised that today's conference may be recorded. (Operator Instructions). I would now like to hand the conference over to your speaker today, Jason Rando at Tiberend Strategic Advisors. Please go ahead.
Good afternoon, everyone, and thank you for joining Salarius Pharmaceuticals Virtual Key Opinion Leader & Investor Event. Before we begin, I would like to remind our listeners that remarks made during this call may contain certain forward-looking statements about operating metrics, future expectations, plans, events and circumstances, including statements about our strategy, future operations and the development and potential effectiveness of our lead investigational drug candidate seclidemstat.
Forward-looking statements are made pursuant to the safe harbor provisions
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)